Institute of Social Sciences, Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation.
Volga district medical center under Federal medical-biology agency, N. Novgorod, Russian Federation.
NPJ Prim Care Respir Med. 2023 Mar 31;33(1):14. doi: 10.1038/s41533-023-00328-9.
The purpose of this study is to conduct a comparative analysis of the impact of the accessibility and quality of medical care provided to patients with chronic noncommunicable diseases (CNCDs) during COVID-19 pandemic on the course and outcome of COVID-19 infection. The study included 132 patients hospitalized with a diagnosis of COVID-19 and having one or more concomitant CNCDs. The patients were divided into two groups based on the quality of the initial CNCD therapy they received. Group 1 involved 58 patients (42%) who received treatment according to clinical guidelines and had a compensated CNCD. Group 2 consisted of 76 patients (58%) who received treatment that was not in line with modern clinical guidelines and/or had a decompensated CNCD. All 'red zone' hospitalized patients were surveyed. In particular, they were asked questions related to the quality and accessibility of medical care during COVID-19 pandemic and their satisfaction with the medical care received during the pandemic. Reduced access to medical care (the failure to have the therapy received timely evaluated and adjusted) during COVID-19 pandemic affects the quality of the therapy received by patients with CNCDs. Generally, an unfavorable course and outcome of COVID-19 infection are typical for patients receiving a non-optimal CNCD therapy as compared to patients receiving a therapy that meets current clinical guidelines.
本研究旨在对 COVID-19 大流行期间向慢性非传染性疾病（CNCD）患者提供的医疗保健的可及性和质量对 COVID-19 感染病程和结局的影响进行对比分析。研究纳入了 132 名因 COVID-19 住院且合并有 1 种或多种 CNCD 的患者。根据初始 CNCD 治疗的质量，将患者分为两组。第 1 组 58 例（42%）患者根据临床指南接受治疗且 CNCD 得到代偿；第 2 组 76 例（58%）患者接受的治疗不符合现代临床指南和/或 CNCD 失代偿。对所有“红色区域”住院患者进行了调查。具体而言，询问了他们有关 COVID-19 大流行期间医疗保健的质量和可及性以及他们对大流行期间所接受医疗保健的满意度的问题。COVID-19 大流行期间医疗保健可及性降低（未能及时评估和调整治疗）会影响 CNCD 患者所接受的治疗质量。通常，与接受符合当前临床指南的治疗的患者相比，接受非最佳 CNCD 治疗的患者 COVID-19 感染的病程和结局更差。
